Screener
Assembly Biosciences ASMB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities | ||
| Accounts payable | $1,129 | $1,171 |
| Accrued research and development expenses | 1,538 | 2,387 |
| Other accrued expenses | 2,664 | 7,749 |
| Deferred revenue from a related party | 29,076 | 36,904 |
| Operating lease liabilities - short-term | 590 | 569 |
| Total current liabilities | 34,997 | 48,780 |
| Operating lease liabilities - long-term | 1,901 | 2,059 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's accrued expenses?
- Assembly Biosciences (ASMB) reported accrued expenses of $2.66M in Q1 2026.
- How has Assembly Biosciences's accrued expenses changed year-over-year?
- Assembly Biosciences's accrued expenses increased by 15.7% year-over-year, from $2.3M to $2.66M.
- What is the long-term trend for Assembly Biosciences's accrued expenses?
- Over 5 years (2020 to 2025), Assembly Biosciences's accrued expenses has grown at a -8.4% compound annual growth rate (CAGR), from $11.99M to $7.75M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Assembly Biosciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude